Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes

Total article views   Abstract views HTML views PDF downloads Totals
7,166 Dovepress* 5,659 582+ 1,266 6,241
PubMed Central* 0 925 336 925
Totals 5,659 1,507 1,602 7,166
*Since 7 September 2018
+Since July 2016

View citations on PubMed Central and Google Scholar